Cynapsus Wants To Offer Parkinson’s Patients A Friendlier Apomorphine Option
This article was originally published in The Pink Sheet Daily
Executive Summary
Sublingual film formulation of apomorphine, just moving into Phase III, would address “off” episodes with fewer side effect issues and easier administration than the current injectable version.